NCT00002598View on ClinicalTrials.gov

Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 1994

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Leukemia
Interventions
BIOLOGICAL

recombinant interferon alfa

BIOLOGICAL

sargramostim

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

etoposide

DRUG

methotrexate

DRUG

mitoxantrone hydrochloride

PROCEDURE

bone marrow ablation with stem cell support

RADIATION

radiation therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002598 - Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter